Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3131290rdf:typepubmed:Citationlld:pubmed
pubmed-article:3131290lifeskim:mentionsumls-concept:C0003232lld:lifeskim
pubmed-article:3131290lifeskim:mentionsumls-concept:C1440044lld:lifeskim
pubmed-article:3131290lifeskim:mentionsumls-concept:C0204727lld:lifeskim
pubmed-article:3131290lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:3131290lifeskim:mentionsumls-concept:C0220807lld:lifeskim
pubmed-article:3131290lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:3131290lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:3131290pubmed:issue4lld:pubmed
pubmed-article:3131290pubmed:dateCreated1988-6-30lld:pubmed
pubmed-article:3131290pubmed:abstractTextMyxococcus flavescens AJ12298 was found to produce the complex of macrocyclic antibiotics named megovalicins. The physico-chemical studies revealed that megovalicins C and B were identical to myxovirescin A1 and antibiotic M-230B, respectively, and that megovalicins A, D, G and H were closely related new antibiotics.lld:pubmed
pubmed-article:3131290pubmed:languageenglld:pubmed
pubmed-article:3131290pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3131290pubmed:citationSubsetIMlld:pubmed
pubmed-article:3131290pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3131290pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3131290pubmed:statusMEDLINElld:pubmed
pubmed-article:3131290pubmed:monthAprlld:pubmed
pubmed-article:3131290pubmed:issn0021-8820lld:pubmed
pubmed-article:3131290pubmed:authorpubmed-author:TakayamaSSlld:pubmed
pubmed-article:3131290pubmed:authorpubmed-author:YamanakaSSlld:pubmed
pubmed-article:3131290pubmed:authorpubmed-author:ShibaiHHlld:pubmed
pubmed-article:3131290pubmed:authorpubmed-author:YokokawaYYlld:pubmed
pubmed-article:3131290pubmed:authorpubmed-author:MiyashiroSSlld:pubmed
pubmed-article:3131290pubmed:issnTypePrintlld:pubmed
pubmed-article:3131290pubmed:volume41lld:pubmed
pubmed-article:3131290pubmed:ownerNLMlld:pubmed
pubmed-article:3131290pubmed:authorsCompleteYlld:pubmed
pubmed-article:3131290pubmed:pagination439-45lld:pubmed
pubmed-article:3131290pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:3131290pubmed:meshHeadingpubmed-meshheading:3131290-...lld:pubmed
pubmed-article:3131290pubmed:meshHeadingpubmed-meshheading:3131290-...lld:pubmed
pubmed-article:3131290pubmed:meshHeadingpubmed-meshheading:3131290-...lld:pubmed
pubmed-article:3131290pubmed:meshHeadingpubmed-meshheading:3131290-...lld:pubmed
pubmed-article:3131290pubmed:meshHeadingpubmed-meshheading:3131290-...lld:pubmed
pubmed-article:3131290pubmed:year1988lld:pubmed
pubmed-article:3131290pubmed:articleTitleNovel macrocyclic antibiotics: megovalicins A, B, C, D, G and H. II. Isolation and chemical structures of megovalicins.lld:pubmed
pubmed-article:3131290pubmed:affiliationCentral Research Laboratories, Ajinomoto Co., Inc., Kanagawa, Japan.lld:pubmed
pubmed-article:3131290pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3131290lld:pubmed